The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/18779
StudyName: Eligibility Parkinson Disease NCT00148512
Date of export from the portal: 02.07.2020
Date of Upload / last change: 20.11.2016
License: Creative Commons BY 4.0

----

Description: 
A Randomized, Double-blind, Placebo-controlled, Five Parallel Groups Efficacy and Safety Study of NS 2330 (Tesofensine) (0.125 mg, 0.25 mg, 0.5 mg and 1.0 mg) Administered Orally Once Daily Over 14 Weeks in Levodopa Treated Parkinson Patients With Motor Fluctuations; ODM derived from: https://clinicaltrials.gov/show/NCT00148512
